171 related articles for article (PubMed ID: 124636)
1. Molecular size difference of urinary heparan sulfates from normal individuals and genetic mucopolysaccharidoses.
Taniguchi N; Miyawaki T; Moriya N; Okuda N
Clin Chim Acta; 1975 May; 60(3):363-9. PubMed ID: 124636
[TBL] [Abstract][Full Text] [Related]
2. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
Toma L; Dietrich CP; Nader HB
Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
[TBL] [Abstract][Full Text] [Related]
3. Chemical definition of the mucopolysaccharidoses.
Constantopoulos G; Dekaban AS
Clin Chim Acta; 1975 Mar; 59(3):321-36. PubMed ID: 123832
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of urinary heparan sulfate in 5 cases of Sanfilippo's syndrome].
Fossati G; Sinigaglia F; Calatroni A
Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1552-8. PubMed ID: 4282024
[No Abstract] [Full Text] [Related]
5. Direct quantitation of glycosaminoglycans in 2 mL of urine from patients with mucopolysaccharidoses.
Burlingame RW; Thomas GH; Stevens RL; Schmid K; Moser HW
Clin Chem; 1981 Jan; 27(1):124-8. PubMed ID: 6778634
[TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
[TBL] [Abstract][Full Text] [Related]
7. Separation of dermatan sulfate from heparan sulfate in mucopolysaccharidosis urine by chromatography on Sephadex G-75.
Herd JK; Forrest T; Tschida J
Clin Chim Acta; 1976 Apr; 68(1):1-9. PubMed ID: 131009
[TBL] [Abstract][Full Text] [Related]
8. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
Zhang H; Wood T; Young SP; Millington DS
Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
[TBL] [Abstract][Full Text] [Related]
9. Hurler's, Hunter's and Morquio's syndromes. A biochemical study in the light of current views of the underlying defects.
Dean MF; Muir H; Ewins RJ
Biochem J; 1971 Aug; 123(5):883-94. PubMed ID: 4256532
[TBL] [Abstract][Full Text] [Related]
10. Mobilization of heparan sulfate induced by immunostimulation in a patient with mucopolysaccharidosis IIIA.
Zerial M; Florio C; Dolzani L; Moro L; Romeo D
Biochem Med; 1984 Apr; 31(2):228-35. PubMed ID: 6232924
[TBL] [Abstract][Full Text] [Related]
11. Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.
Gallegos-Arreola MP; González-Noriega A; Zúñiga-González GM; Flores-Martínez SE; Morán Moguel MC; Figuera LE; Sánchez-Corona J
Arch Med Res; 1997; 28(1):91-4. PubMed ID: 9078594
[TBL] [Abstract][Full Text] [Related]
12. Liquid-chromatographic determination of urinary glycosaminoglycans for differential diagnosis of genetic mucopolysaccharidoses.
Kodama C; Ototani N; Isemura M; Aikawa J; Yosizawa Z
Clin Chem; 1986 Jan; 32(1 Pt 1):30-4. PubMed ID: 3079683
[TBL] [Abstract][Full Text] [Related]
13. Characterization of dermatan sulfate and heparan sulfate in the urine of a patient with the Hunter syndrome.
Kimura A; Hayashi S; Tsurumi K
Tohoku J Exp Med; 1980 Jul; 131(3):227-39. PubMed ID: 6447930
[TBL] [Abstract][Full Text] [Related]
14. Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine.
Coppa GV; Gabrielli O; Zampini L; Maccari F; Mantovani V; Galeazzi T; Santoro L; Padella L; Marchesiello RL; Galeotti F; Volpi N
Metab Brain Dis; 2015 Dec; 30(6):1343-8. PubMed ID: 26016623
[TBL] [Abstract][Full Text] [Related]
15. Fractionation and characterization of urinary heparan sulfate excreted by patients with Sanfilippo syndrome.
Kimura A; Hayashi S; Koseki M; Kochi H; Tsurumi K
Tohoku J Exp Med; 1984 Nov; 144(3):227-36. PubMed ID: 6240800
[TBL] [Abstract][Full Text] [Related]
16. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
Auray-Blais C; Bhérer P; Gagnon R; Young SP; Zhang HH; An Y; Clarke JT; Millington DS
Mol Genet Metab; 2011 Jan; 102(1):49-56. PubMed ID: 20934363
[TBL] [Abstract][Full Text] [Related]
17. Comparative structural studies of urinary glycosaminoglycans in the Hurler and Hunter syndromes.
Ramage P; Cunningham WL
Biochim Biophys Acta; 1975 Dec; 411(2):325-33. PubMed ID: 127616
[TBL] [Abstract][Full Text] [Related]
18. Rapid identification of San Filippo disease (MPS III).
Kelly S; Schedlbauer L; Leikhim E
Health Lab Sci; 1978 Jul; 15(3):123-7. PubMed ID: 151669
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of urinary glycosaminoglycans excreted by a patient with the Hurler-Scheie compound syndrome.
Kimura A; Hayashi S; Koseki M; Tsurumi K
Tohoku J Exp Med; 1982 Jan; 136(1):61-6. PubMed ID: 6803394
[TBL] [Abstract][Full Text] [Related]
20. Studies on the composition of urinary glycosaminoglycans and oligosaccharides in patients with mucopolysaccharidoses who were receiving fibroblast transplants.
Purkiss P; Gibbs DA; Watts RW
Clin Chim Acta; 1983 Jun; 131(1-2):109-21. PubMed ID: 6411385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
